1Paul L, Fidel Jr. Immunity in vaginal candidiasis. Current Opinion in Infectious Disease ,2005,18 : 107-111.
2Faro S. Differential diagnosis and Management. Vaginitis:Parthenon Publishing, 2004,45 -65.
3Yun Chang J, oh YK, Soo Kong H, et al. Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release,2002,82:39-50.
4Del Palacio A, Sanz F, Sanchez-Alor G, et al. Double-blind randomized dose-finding study in acute vulvovaginal candidosis. Comparison of flutrimazole site-release cream( 1,2 and 4% )with place bosite-release vaginal Cream. Mycoses. 2000,43:355-365.
5White DJ, Habib AR, Vanthuyne A, et al. Combined topical flueytosine and amphotericin B for refractory vaginal Candida glabrata infections. Sex Transm Infect,2001,77:212-213.
6Clemons KV, Stevens DA. Eficacy of ravuconazole in treatment of mucosal candidosis in SCID mice. Antimicrob Agents Chemother, 2001,45:3433-3436.
7Petraitis V, Petraitiene R, Groll AH, et al. Dosage-dependent anti- fungal eficacy of V-echinocandin ( LY303366 ) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrob Agents Chemother,2001,45:471-479.
8Lass-Florl C, Diefich MP, Fuchs D, et al. Anfifungal activity against Candida species of the selective semtonin-reuptake inhibitor, sertraline. Clin Infect Dis,2001,33:135-136.
9Altamura M, Casale D, Pepe M, et al. Immune responses to fungal infections and therapeutic implica-tions. Curt Drug Targets Immune Endoer Metabol Disord ,2001,1 : 189-197.
